Publications dans lesquelles il/elle collabore avec IÑAKI ROBLES VERA (38)

2023

  1. Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung

    Nature communications, Vol. 14, Núm. 1, pp. 6090

  2. Mineralocorticoid receptor blockade improved gut microbiota dysbiosis by reducing gut sympathetic tone in spontaneously hypertensive rats

    Biomedicine and Pharmacotherapy, Vol. 158

  3. Protective effect of microbiota-derived short chain fatty acids on vascular dysfunction in mice with systemic lupus erythematosus induced by toll like receptor 7 activation

    Pharmacological Research, Vol. 198

  4. Solanum aethiopicum L. from the Basilicata region as a source of specialized metabolites with promising anti-obesity effects: phytochemical characterization and in vivo investigation in high fat diet-fed mice

    Frontiers in Pharmacology, Vol. 14

  5. Targeting the gut microbiota with dietary fibers: a novel approach to prevent the development cardiovascular complications linked to systemic lupus erythematosus in a preclinical study

    Gut Microbes, Vol. 15, Núm. 2

  6. The Prebiotic Effects of an Extract with Antioxidant Properties from Morus alba L. Contribute to Ameliorate High-Fat Diet-Induced Obesity in Mice

    Antioxidants, Vol. 12, Núm. 4

2022

  1. Conventional type 1 dendritic cells protect against age-related adipose tissue dysfunction and obesity

    Cellular and Molecular Immunology, Vol. 19, Núm. 2, pp. 260-275

  2. Trimethylamine n-oxide promotes autoimmunity and a loss of vascular function in toll-like receptor 7-driven lupus mice

    Antioxidants, Vol. 11, Núm. 1

2021

  1. Changes in gut microbiota induced by doxycycline influence in vascular function and development of hypertension in doca-salt rats

    Nutrients, Vol. 13, Núm. 9

  2. Gut microbiota contributes to the development of hypertension in a genetic mouse model of systemic lupus erythematosus

    British Journal of Pharmacology, Vol. 178, Núm. 18, pp. 3708-3729

  3. Gut microbiota has a crucial role in the development of hypertension and vascular dysfunction in toll-like receptor 7-driven lupus autoimmunity

    Antioxidants, Vol. 10, Núm. 9

  4. Lactobacillus fermentum CECT5716 ameliorates high fat diet-induced obesity in mice through modulation of gut microbiota dysbiosis

    Pharmacological Research, Vol. 167

  5. Mycophenolate mediated remodeling of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rats

    Biomedicine and Pharmacotherapy, Vol. 135

  6. Probiotics prevent hypertension in a murine model of systemic lupus erythematosus induced by toll-like receptor 7 activation

    Nutrients, Vol. 13, Núm. 8

2020

  1. Changes to the gut microbiota induced by losartan contributes to its antihypertensive effects

    British Journal of Pharmacology, Vol. 177, Núm. 9, pp. 2006-2023

  2. Gut DYSBIOSIS and altered barrier function precedes the appearance of metabolic syndrome in a rat model of nutrient-induced catch-up growth

    Journal of Nutritional Biochemistry, Vol. 81

  3. Gut Pathology and Its Rescue by ACE2 (Angiotensin-Converting Enzyme 2) in Hypoxia-Induced Pulmonary Hypertension

    Hypertension, Vol. 76, Núm. 1, pp. 206-216

  4. Lactobacillus fermentum CECT5716 prevents renal damage in the NZBWF1 mouse model of systemic lupus erythematosus

    Food & function, Vol. 11, Núm. 6, pp. 5266-5274

  5. Microbiota and Hypertension: Role of the Sympathetic Nervous System and the Immune System

    American journal of hypertension, Vol. 33, Núm. 10, pp. 890-901

  6. Microbiota intestinal en hipertensión. Papel del sistema inmunológico

    Microbiota intestinal en hipertensión. Papel del sistema inmunológico